首页 > 最新文献

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases最新文献

英文 中文
Mycobacterium tuberculosis infection status and associated factors among household close contacts of rifampicin-resistant pulmonary tuberculosis patients: A single-center cross-sectional study 耐利福平肺结核患者家庭密切接触者结核分枝杆菌感染状况及相关因素:一项单中心横断面研究
IF 2 Q3 INFECTIOUS DISEASES Pub Date : 2025-09-12 DOI: 10.1016/j.jctube.2025.100561
Zhengyu Shi , Juan Peng , Xiu Li , Xiaoyan Fu , Liping Zou , Qin Chen , Tao Huang , Yu Zhou , Hongmei Zhu , Yi Wang , Shenjie Tang , Guihui Wu
<div><h3>Background</h3><div>Rifampicin-resistant tuberculosis (RR-TB) is a major global public health challenge. Household close contacts (HHCs) of RR-TB patients face a high risk of <em>Mycobacterium tuberculosis</em> infection. Southwestern China carries a heavy RR-TB burden, yet research data on the infection status of this population remain scarce. This study aimed to evaluate the incidence of latent tuberculosis infection (LTBI) and active tuberculosis disease (TBD) and their associated factors among HHCs of RR-TB patients in this region through active screening, providing data support for optimizing regional RR-TB prevention and control strategies.</div></div><div><h3>Methods</h3><div>Using a cross-sectional design, HHCs of RR-TB patients diagnosed at Chengdu Public Health Clinical Medical Center from October 1, 2023, to March 30, 2025, were enrolled. Clinical data were collected via a self-designed questionnaire including gender, age, body mass index (BMI), relationship to index case, living environment, chronic comorbidities, medication history, and TBD-suspicious symptom screening. TBD screening used chest digital radiography (DR) or computed tomography (CT). Clinical data of index cases were extracted from the hospital information system (HIS), covering sputum acid-fast bacillus smear, sputum mycobacterial culture, sputum molecular testing for M. tuberculosis, fluoroquinolone resistance, extent of pulmonary lesions, and cavitation status. TB infection screening employed tuberculin skin test (TST), ESAT6-CFP10 fusion protein skin test (EC), or interferon-γ release assays (IGRA). Infection status was categorized as uninfected, LTBI, or TBD based on screening results, clinical symptoms, and imaging findings. Incidence rates of LTBI and TBD were calculated. Chi-square tests compared clinical characteristics across infection states. Multivariable logistic regression analyzed factors associated with LTBI and TBD (versus uninfected).</div></div><div><h3>Results</h3><div>264 HHCs from 197 RR-TB index cases were included: 113 males (42.8 %), 151 females (57.2 %), aged 3–78 years (mean 42.4 ± 15.1). Among 209 participants tested with TST: 117 (44.3 %) had induration diameter [0, 5) mm, 17 (6.4 %) [5, 10) mm, 30 (11.4 %) [10, 15) mm, 45 (17.1 %) ≥ 15 mm. Among 46 EC-tested: 29 (11.0 %) had [0, 5) mm, 17 (6.4 %) ≥ 5 mm. Among 9 IGRA-tested: 1 (0.4 %) negative, 8 (3.0 %) positive. After cluster-effect adjustment, LTBI incidence was 31.2 % (95 % confidence interval [CI]: 25.8–38.3), TBD incidence 9.9 % (95 % CI: 6.4–13.6). The proportion of spousal relationships to index cases was higher in LTBI/TBD groups than uninfected (P < 0.05). BMI < 18.5 kg/m<sup>2</sup> and positive TBD symptom screening were more frequent in TBD than uninfected/LTBI groups (P < 0.05). Pulmonary cavitation in index cases was more common in TBD contacts (P < 0.05). Multivariable analysis showed spousal relationship was an independent associated factor for LTBI (ad
耐利福平结核病(RR-TB)是一项重大的全球公共卫生挑战。RR-TB患者的家庭密切接触者(HHCs)面临结核分枝杆菌感染的高风险。中国西南地区是耐药结核病的重灾区,但有关该地区人群感染状况的研究数据仍然很少。本研究旨在通过主动筛查,评估该地区RR-TB患者hhc中潜伏性结核感染(LTBI)和活动性结核病(TBD)的发病率及其相关因素,为优化区域RR-TB防控策略提供数据支持。方法采用横断面设计,纳入2023年10月1日至2025年3月30日在成都市公共卫生临床医学中心诊断的RR-TB患者的hhc。通过自行设计的问卷收集临床资料,包括性别、年龄、体重指数(BMI)、与指标病例的关系、生活环境、慢性合并症、用药史、tbd可疑症状筛查等。TBD筛查采用胸部数字x线摄影(DR)或计算机断层扫描(CT)。从医院信息系统(HIS)中提取指标病例的临床资料,包括痰中抗酸杆菌涂片、痰中分枝杆菌培养、痰中结核分枝杆菌分子检测、氟喹诺酮类药物耐药性、肺部病变程度、空化情况等。结核感染筛查采用结核菌素皮肤试验(TST)、ESAT6-CFP10融合蛋白皮肤试验(EC)或干扰素γ释放试验(IGRA)。根据筛查结果、临床症状和影像学表现,感染状态分为未感染、LTBI或TBD。计算LTBI和TBD的发病率。卡方检验比较了不同感染状态的临床特征。多变量逻辑回归分析了与LTBI和TBD相关的因素(相对于未感染)。结果197例RR-TB指标病例共检出264例hhc:男性113例(42.8%),女性151例(57.2%),年龄3 ~ 78岁(平均42.4±15.1)。在209名接受TST测试的参与者中,117名(44.3%)患者的硬结直径为[0,5)mm, 17名(6.4%)[5,10]mm, 30名(11.4%)[10,15]mm, 45名(17.1%)≥15 mm。在46 EC-tested: 29(11.0%)[0, 5)毫米,17(6.4%)≥5毫米。9例igra检测:1例(0.4%)阴性,8例(3.0%)阳性。经聚类效应调整后,LTBI发生率为31.2%(95%可信区间[CI]: 25.8-38.3), TBD发生率为9.9% (95% CI: 6.4-13.6)。LTBI/TBD组配偶关系占指标病例的比例高于未感染组(P < 0.05)。BMI 18.5 kg/m2和TBD阳性症状筛查在TBD组比未感染/LTBI组更频繁(P < 0.05)。指标病例肺空化在TBD接触者中更为常见(P < 0.05)。多变量分析显示,配偶关系是LTBI的独立相关因素(校正优势比[aOR] = 2.102, 95% CI = 1.201 ~ 3.677; P = 0.009)。与TBD相关的因素包括:配偶关系(aOR = 3.949, 95% CI = 1.553 ~ 10.042; P = 0.004)、TBD阳性症状(aOR = 41.988, 95% CI = 4.270 ~ 412.886; P = 0.001)、指标病例肺空化(aOR = 2.881, 95% CI = 1.103 ~ 7.523; P = 0.031)。结论该地区RR-TB人群存在较高的LTBI和TBD发生率。配偶关系是LTBI和TBD的危险因素;TBD阳性症状和肺空化与TBD相关。建议积极筛查RR-TB HHCs并采取风险分层控制策略,以阻断传播链。
{"title":"Mycobacterium tuberculosis infection status and associated factors among household close contacts of rifampicin-resistant pulmonary tuberculosis patients: A single-center cross-sectional study","authors":"Zhengyu Shi ,&nbsp;Juan Peng ,&nbsp;Xiu Li ,&nbsp;Xiaoyan Fu ,&nbsp;Liping Zou ,&nbsp;Qin Chen ,&nbsp;Tao Huang ,&nbsp;Yu Zhou ,&nbsp;Hongmei Zhu ,&nbsp;Yi Wang ,&nbsp;Shenjie Tang ,&nbsp;Guihui Wu","doi":"10.1016/j.jctube.2025.100561","DOIUrl":"10.1016/j.jctube.2025.100561","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Rifampicin-resistant tuberculosis (RR-TB) is a major global public health challenge. Household close contacts (HHCs) of RR-TB patients face a high risk of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection. Southwestern China carries a heavy RR-TB burden, yet research data on the infection status of this population remain scarce. This study aimed to evaluate the incidence of latent tuberculosis infection (LTBI) and active tuberculosis disease (TBD) and their associated factors among HHCs of RR-TB patients in this region through active screening, providing data support for optimizing regional RR-TB prevention and control strategies.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Using a cross-sectional design, HHCs of RR-TB patients diagnosed at Chengdu Public Health Clinical Medical Center from October 1, 2023, to March 30, 2025, were enrolled. Clinical data were collected via a self-designed questionnaire including gender, age, body mass index (BMI), relationship to index case, living environment, chronic comorbidities, medication history, and TBD-suspicious symptom screening. TBD screening used chest digital radiography (DR) or computed tomography (CT). Clinical data of index cases were extracted from the hospital information system (HIS), covering sputum acid-fast bacillus smear, sputum mycobacterial culture, sputum molecular testing for M. tuberculosis, fluoroquinolone resistance, extent of pulmonary lesions, and cavitation status. TB infection screening employed tuberculin skin test (TST), ESAT6-CFP10 fusion protein skin test (EC), or interferon-γ release assays (IGRA). Infection status was categorized as uninfected, LTBI, or TBD based on screening results, clinical symptoms, and imaging findings. Incidence rates of LTBI and TBD were calculated. Chi-square tests compared clinical characteristics across infection states. Multivariable logistic regression analyzed factors associated with LTBI and TBD (versus uninfected).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;264 HHCs from 197 RR-TB index cases were included: 113 males (42.8 %), 151 females (57.2 %), aged 3–78 years (mean 42.4 ± 15.1). Among 209 participants tested with TST: 117 (44.3 %) had induration diameter [0, 5) mm, 17 (6.4 %) [5, 10) mm, 30 (11.4 %) [10, 15) mm, 45 (17.1 %) ≥ 15 mm. Among 46 EC-tested: 29 (11.0 %) had [0, 5) mm, 17 (6.4 %) ≥ 5 mm. Among 9 IGRA-tested: 1 (0.4 %) negative, 8 (3.0 %) positive. After cluster-effect adjustment, LTBI incidence was 31.2 % (95 % confidence interval [CI]: 25.8–38.3), TBD incidence 9.9 % (95 % CI: 6.4–13.6). The proportion of spousal relationships to index cases was higher in LTBI/TBD groups than uninfected (P &lt; 0.05). BMI &lt; 18.5 kg/m&lt;sup&gt;2&lt;/sup&gt; and positive TBD symptom screening were more frequent in TBD than uninfected/LTBI groups (P &lt; 0.05). Pulmonary cavitation in index cases was more common in TBD contacts (P &lt; 0.05). Multivariable analysis showed spousal relationship was an independent associated factor for LTBI (ad","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100561"},"PeriodicalIF":2.0,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145104935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revisiting the therapeutic threshold in tuberculosis Care: Lessons from Southern Africa’s dual-method approach 重新审视结核病护理的治疗门槛:来自南部非洲双重方法的经验教训
IF 2 Q3 INFECTIOUS DISEASES Pub Date : 2025-08-27 DOI: 10.1016/j.jctube.2025.100560
Chadaporn N. Gordon , Nav La , Schawanya K. Rattanapitoon , Nathkapach K. Rattanapitoon
{"title":"Revisiting the therapeutic threshold in tuberculosis Care: Lessons from Southern Africa’s dual-method approach","authors":"Chadaporn N. Gordon ,&nbsp;Nav La ,&nbsp;Schawanya K. Rattanapitoon ,&nbsp;Nathkapach K. Rattanapitoon","doi":"10.1016/j.jctube.2025.100560","DOIUrl":"10.1016/j.jctube.2025.100560","url":null,"abstract":"","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100560"},"PeriodicalIF":2.0,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144913957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distribution of nontuberculous Mycobacteria among presumptive drug resistance tuberculosis patients from a ministry of health drug resistance surveillance program, in western Kenya 肯尼亚西部卫生部耐药性监测项目推定耐药结核病患者中非结核分枝杆菌的分布情况
IF 2 Q3 INFECTIOUS DISEASES Pub Date : 2025-08-19 DOI: 10.1016/j.jctube.2025.100559
Okumu Albert , Odeny Lazarus , Ochieng John Benjamin , Odhiambo Ben , Sitati Ruth , Tonui Joan , Ogoro Jeremiah , Wandiga Steve , Collins Ouma

Introduction

Nontuberculous Mycobacteria (NTM) species are emerging pathogens causing Pulmonary diseases with no definitive treatment. Molecular techniques enable characterization and drug resistance profiling, this study sought to determine NTM prevalence, circulating species, and distribution factors among presumptive multidrug-resistant tuberculosis (MDR-TB) patients in western Kenya.

Method

Sputum samples were collected between March through October 2022, and transported for testing at Kenya Medical Research Institute (KEMRI) TB laboratory, in Kisumu. The standard NALC-NaOH MGIT culture technique, smear, HAIN AS/CM and NTM drug resistance were carried out.

Results

Of the 155 specimens analyzed, 106 (68.4 %) were males, 41 (26.5 %) HIV positive, and participants of ages 36–45 years, the majority. An overall NTM prevalence of 99 (63.9 %), of whom 63 (63 %) among males reported. In addition, 11 NTM species identified, with M. intracellulare (44, 44 %).

Conclusions

High prevalence of NTM species was observed among middle-aged males and HIV negative participants, Kisumu led in distribution (29 %) and among HIV positive. The NTM prevalence among smear negative vs smear positive, was significant a p < 0.001, hence adequate TB/HIV integration and management, use of molecular techniques, and accurate identification is critical.
非结核分枝杆菌(NTM)是一种新出现的病原体,可引起肺部疾病,尚无明确的治疗方法。分子技术使表征和耐药谱分析成为可能,本研究试图确定肯尼亚西部推定的耐多药结核病(MDR-TB)患者中NTM的流行、传播种类和分布因素。方法于2022年3月至10月期间收集痰样本,并将其运往基苏木的肯尼亚医学研究所(KEMRI)结核病实验室进行检测。进行标准NALC-NaOH MGIT培养技术、涂片、HAIN AS/CM和NTM耐药试验。结果155份样本中,男性106份(68.4%),HIV阳性41份(26.5%),年龄以36-45岁为主。总体NTM患病率为99例(63.9%),其中63例(63%)为男性。此外,鉴定出11种NTM,其中胞内分枝杆菌占44.44%。结论NTM在中年男性和HIV阴性人群中患病率较高,以Kisumu(29%)和HIV阳性人群中分布最多。涂片阴性和涂片阳性的NTM患病率显著(p < 0.001),因此,充分的结核/艾滋病毒整合和管理、使用分子技术和准确识别至关重要。
{"title":"Distribution of nontuberculous Mycobacteria among presumptive drug resistance tuberculosis patients from a ministry of health drug resistance surveillance program, in western Kenya","authors":"Okumu Albert ,&nbsp;Odeny Lazarus ,&nbsp;Ochieng John Benjamin ,&nbsp;Odhiambo Ben ,&nbsp;Sitati Ruth ,&nbsp;Tonui Joan ,&nbsp;Ogoro Jeremiah ,&nbsp;Wandiga Steve ,&nbsp;Collins Ouma","doi":"10.1016/j.jctube.2025.100559","DOIUrl":"10.1016/j.jctube.2025.100559","url":null,"abstract":"<div><h3>Introduction</h3><div>Nontuberculous Mycobacteria (NTM) species are emerging pathogens causing Pulmonary diseases with no definitive treatment. Molecular techniques enable characterization and drug resistance profiling, this study sought to determine NTM prevalence, circulating species, and distribution factors among presumptive multidrug-resistant tuberculosis (MDR-TB) patients in western Kenya.</div></div><div><h3>Method</h3><div>Sputum samples were collected between March through October 2022, and transported for testing at Kenya Medical Research Institute (KEMRI) TB laboratory, in Kisumu. The standard NALC-NaOH MGIT culture technique, smear, HAIN AS/CM and NTM drug resistance were carried out.</div></div><div><h3>Results</h3><div>Of the 155 specimens analyzed, 106 (68.4 %) were males, 41 (26.5 %) HIV positive, and participants of ages 36–45 years, the majority. An overall NTM prevalence of 99 (63.9 %), of whom 63 (63 %) among males reported. In addition, 11 NTM species identified, with <em>M. intracellulare</em> (44, 44 %).</div></div><div><h3>Conclusions</h3><div>High prevalence of NTM species was observed among middle-aged males and HIV negative participants, Kisumu led in distribution (29 %) and among HIV positive. The NTM prevalence among smear negative vs smear positive, was significant a p &lt; 0.001, hence adequate TB/HIV integration and management, use of molecular techniques, and accurate identification is critical.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100559"},"PeriodicalIF":2.0,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144879532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term occupational risk of latent tuberculosis infection in Hamburg, Germany: Findings from a 13-year prospective observational study 德国汉堡潜伏结核感染的长期职业风险:一项为期13年的前瞻性观察研究的结果
IF 2 Q3 INFECTIOUS DISEASES Pub Date : 2025-08-13 DOI: 10.1016/j.jctube.2025.100558
Roland Diel , Matthias Gröschel , Albert Nienhaus

Background

Only limited population-based data are available on the risk of latent tuberculosis infection (LTBI) in health care workers (HCWs).

Objective

To assess the long-term effects of protective measures of HCWs on LTBI risk in Hamburg, Germany.

Methods

Close contacts of smear-positive and smear-negative, but culture-confirmed, pulmonary TB index cases were prospectively enrolled from June 2005 to December 2017 and tested with the QuantiFERON TB (QFT) test approximately eight weeks after last exposure. Sociodemographic and clinical data were collected by trained healthcare personnel using a standardized questionnaire.
Contacts with known previous positive TST or IGRA results were excluded.

Results

After exclusion of prevalent TB cases and contact persons who had been tested positive in other settings, valid results were available for 937 index cases and 6980 close contacts (average per case 7.45; standard deviation (SD) ± 9.99; range 1–83). Of the contacts, 3459 (49.6 %) were males and 3520 (50.4 %) females. 771 contacts (11.05 %) belonged to 11 HCW subgroups, most of them (475, or 62.8 %) hospital or geriatric nurses. Foreign-born HCW did not differ significantly from non-HCW regarding origin from high-incidence countries.
By adjusting for confounders, logistic regression analysis confirmed household contact as strongest predictor for acquiring LTBI (OR 3.8, p < 0.001), followed by foreign-born status (OR 2.2, p < 0.001) and male gender (OR 1.28, p < 0.001). Contact with a smear-positive index case only slightly increased the risk of IGRA positivity, by 16 % (OR 1.16, p = 0.024). For each additional year of age, higher odds were found at 1.86 % (OR 1.019, p < 0.001] and for each additional hour of contact at approximately 0.11 % (OR 1.011, p < 0.001). BCG vaccination had no significant effect on IGRA test results (OR 0.95, p = 0.41).
Employment in healthcare overall was associated with a 26 % lower risk of IGRA positivity compared to non-HCWs (OR 0.74, p = 0.013); however, in a second adjusted model focusing on specific HCW subgroups, this risk reduction was statistically significant only for hospital and geriatric nurses, with no significant difference observed in other HCW subgroups.

Conclusion

Working in a health-care facility overall was associated with a lower LTBI risk compared to other risk factors. These findings suggest that protective measures might be particularly effective in hospital and geriatric nursing, while no risk reduction was evident for other HCW subgroups. Continued targeted protective measures remain important in high-risk care environments and support the relevance of recommendations issued (and last updated 2023) by the German Central Committee against Tuberculosis (DZK).
背景:关于卫生保健工作者(HCWs)潜伏性结核感染(LTBI)风险的基于人群的数据有限。目的评价德国汉堡地区医护人员防护措施对LTBI风险的长期影响。方法前瞻性纳入2005年6月至2017年12月期间痰检阳性和痰检阴性但经培养确诊的肺结核指数病例的密切接触者,并在最后一次接触后约8周进行QuantiFERON TB (QFT)检测。社会人口学和临床数据由训练有素的卫生保健人员使用标准化问卷收集。排除已知既往TST或IGRA阳性的接触者。结果在排除结核病流行病例和其他场所检测阳性的接触者后,对937例指数病例和6980例密切接触者(平均每例7.45例;标准偏差(SD)±9.99;范围1 - 83)。其中男性3459例(49.6%),女性3520例(50.4%)。771名接触者(11.05%)属于11个HCW亚组,其中大多数是医院或老年护士(475名,62.8%)。在高发病率国家的来源方面,外国出生的HCW与非HCW没有显著差异。通过调整混杂因素,逻辑回归分析证实家庭接触是获得LTBI的最强预测因子(OR 3.8, p <;0.001),其次是外国出生身份(OR 2.2, p <;0.001)和男性(OR 1.28, p <;0.001)。与涂片阳性指标病例接触仅略微增加IGRA阳性的风险,增加16% (OR 1.16, p = 0.024)。每增加1岁,患病几率增加1.86% (OR 1.019, p <;0.001]并且每增加一小时的接触,大约0.11% (OR 1.011, p <;0.001)。卡介苗接种对IGRA检测结果无显著影响(OR 0.95, p = 0.41)。总体而言,与非卫生保健工作者相比,卫生保健工作者IGRA阳性风险降低26% (OR 0.74, p = 0.013);然而,在针对特定HCW亚组的第二个调整模型中,这种风险降低仅在医院和老年护士中具有统计学意义,在其他HCW亚组中没有观察到显著差异。结论与其他危险因素相比,在卫生保健机构工作总体上与较低的LTBI风险相关。这些发现表明,保护措施可能在医院和老年护理中特别有效,而对其他HCW亚组没有明显的风险降低。在高风险护理环境中,继续采取有针对性的保护措施仍然很重要,并支持德国防治结核病中央委员会(DZK)发布的建议(最后一次更新于2023年)的相关性。
{"title":"Long-term occupational risk of latent tuberculosis infection in Hamburg, Germany: Findings from a 13-year prospective observational study","authors":"Roland Diel ,&nbsp;Matthias Gröschel ,&nbsp;Albert Nienhaus","doi":"10.1016/j.jctube.2025.100558","DOIUrl":"10.1016/j.jctube.2025.100558","url":null,"abstract":"<div><h3>Background</h3><div>Only limited population-based data are available on the risk of latent tuberculosis infection (LTBI) in health care workers (HCWs).</div></div><div><h3>Objective</h3><div>To assess the long-term effects of protective measures of HCWs on LTBI risk in Hamburg, Germany.</div></div><div><h3>Methods</h3><div>Close contacts of smear-positive and smear-negative, but culture-confirmed, pulmonary TB index cases were prospectively enrolled from June 2005 to December 2017 and tested with the QuantiFERON TB (QFT) test approximately eight weeks after last exposure<strong>.</strong> Sociodemographic and clinical data were collected by trained healthcare personnel using a standardized questionnaire.</div><div>Contacts with known previous positive TST or IGRA results were excluded.</div></div><div><h3>Results</h3><div>After exclusion of prevalent TB cases and contact persons who had been tested positive in other settings, valid results were available for 937 index cases and 6980 close contacts (average per case 7.45; standard deviation (SD) ± 9.99; range 1–83). Of the contacts, 3459 (49.6 %) were males and 3520 (50.4 %) females. 771 contacts (11.05 %) belonged to 11 HCW subgroups, most of them (475, or 62.8 %) hospital or geriatric nurses. Foreign-born HCW did not differ significantly from non-HCW regarding origin from high-incidence countries.</div><div>By adjusting for confounders, logistic regression analysis confirmed household contact as strongest predictor for acquiring LTBI (OR 3.8, p &lt; 0.001), followed by foreign-born status (OR 2.2, p &lt; 0.001) and male gender (OR 1.28, p &lt; 0.001). Contact with a smear-positive index case only slightly increased the risk of IGRA positivity, by 16 % (OR 1.16, p = 0.024). For each additional year of age, higher odds were found at 1.86 % (OR 1.019, p &lt; 0.001] and for each additional hour of contact at approximately 0.11 % (OR 1.011, p &lt; 0.001). BCG vaccination had no significant effect on IGRA test results (OR 0.95, p = 0.41).</div><div>Employment in healthcare overall was associated with a 26 % lower risk of IGRA positivity compared to non-HCWs (OR 0.74, p = 0.013); however, in a second adjusted model focusing on specific HCW subgroups, this risk reduction was statistically significant only for hospital and geriatric nurses, with no significant difference observed in other HCW subgroups.</div></div><div><h3>Conclusion</h3><div>Working in a health-care facility overall was associated with a lower LTBI risk compared to other risk factors<del>.</del> These findings suggest that protective measures might be particularly effective in hospital and geriatric nursing, while no risk reduction was evident for other HCW subgroups. Continued targeted protective measures remain important in high-risk care environments and support the relevance of recommendations issued (and last updated 2023) by the German Central Committee against Tuberculosis (DZK).</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100558"},"PeriodicalIF":2.0,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144842539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symptomatic (STB) and Asymptomatic (ATB) tuberculosis in Italy: Results from a multicenter retrospective study 意大利有症状肺结核(STB)和无症状肺结核(ATB):一项多中心回顾性研究的结果
IF 2 Q3 INFECTIOUS DISEASES Pub Date : 2025-08-10 DOI: 10.1016/j.jctube.2025.100556
Sergio Cotugno , Giacomo Guido , Francesco Di Gennaro , Francesco Cavallin , Mariantonietta Pisaturo , Lorenzo Onorato , Federica Zimmerhofer , Luca Pipitò , Giuseppina De Iaco , Giuseppe Bruno , Massimo Fasano , Agostina Pontarelli , Annarita Botta , Tiziana Iacovazzi , Rossana Lattanzio , Roberta Papagni , Elda De Vita , Alberto Zolezzi , Gianfranco Panico , Raffaella Libertone , Annalisa Saracino

Objective

Asymptomatic tuberculosis (ATB) represents a significant proportion of tuberculosis (TB) cases. This study aimed to compare ATB and symptomatic TB (STB) cases in terms of demographic and clinical characteristics, adverse events, hospital length of stay, and treatment outcomes.

Methods

This multicenter retrospective study included 510 microbiologically confirmed pulmonary TB patients across ten Italian hospitals between 2018 and 2023. STB cases presented with at least one symptom such as cough, fever, chest pain, hemoptysis, dyspnea, night sweats or weight loss. ATB cases presented with no symptoms. The endpoints included adverse events, length of hospital stay, and incompleteness of the treatment.

Results

ATB accounted for 36.4 % of cases (184/510). STB was significantly associated with diabetes (p = 0.03), hepatitis B/C infections (p < 0.0001), and history of TB (p = 0.01). Adjusting for clinically relevant confounders, STB was associated with higher occurrence of adverse events (odds ratio 2.04, 95 % confidence interval 1.31 to 3.23; p = 0.002), more severe adverse events (odds ratio 8.07, 95 % confidence interval 2.58 to 33.34; p = 0.001) and a 24 % increase in length of hospital stay (95 % confidence interval 7 % to 47 %; p = 0.005), but was not associated with incomplete treatment (odds ratio 0.79, 95 % confidence interval 0.47 to 1.32; p = 0.37).

Conclusions

STB is associated with a higher burden of adverse events. ATB poses challenges for TB elimination due to its asymptomatic nature.
目的无症状结核病(ATB)占结核病(TB)病例的很大比例。本研究旨在比较ATB和症状性结核病(STB)病例在人口学和临床特征、不良事件、住院时间和治疗结果方面的差异。方法本多中心回顾性研究纳入了2018年至2023年间意大利10家医院的510例微生物学证实的肺结核患者。性病例至少有一种症状,如咳嗽、发热、胸痛、咯血、呼吸困难、盗汗或体重减轻。ATB病例无症状。终点包括不良事件、住院时间和治疗的不完全性。结果satb占36.4%(184/510)。STB与糖尿病(p = 0.03)、乙型/丙型肝炎感染(p <;0.0001)和结核病史(p = 0.01)。调整临床相关混杂因素后,STB与较高的不良事件发生率相关(优势比2.04,95%可信区间1.31 ~ 3.23;P = 0.002),更严重的不良事件(优势比8.07,95%可信区间2.58 ~ 33.34;P = 0.001),住院时间增加24%(95%置信区间为7%至47%;P = 0.005),但与治疗不完全无关(优势比0.79,95%可信区间0.47 ~ 1.32;p = 0.37)。结论stb与较高的不良事件负担相关。由于ATB的无症状性,它对消除结核病提出了挑战。
{"title":"Symptomatic (STB) and Asymptomatic (ATB) tuberculosis in Italy: Results from a multicenter retrospective study","authors":"Sergio Cotugno ,&nbsp;Giacomo Guido ,&nbsp;Francesco Di Gennaro ,&nbsp;Francesco Cavallin ,&nbsp;Mariantonietta Pisaturo ,&nbsp;Lorenzo Onorato ,&nbsp;Federica Zimmerhofer ,&nbsp;Luca Pipitò ,&nbsp;Giuseppina De Iaco ,&nbsp;Giuseppe Bruno ,&nbsp;Massimo Fasano ,&nbsp;Agostina Pontarelli ,&nbsp;Annarita Botta ,&nbsp;Tiziana Iacovazzi ,&nbsp;Rossana Lattanzio ,&nbsp;Roberta Papagni ,&nbsp;Elda De Vita ,&nbsp;Alberto Zolezzi ,&nbsp;Gianfranco Panico ,&nbsp;Raffaella Libertone ,&nbsp;Annalisa Saracino","doi":"10.1016/j.jctube.2025.100556","DOIUrl":"10.1016/j.jctube.2025.100556","url":null,"abstract":"<div><h3>Objective</h3><div>Asymptomatic tuberculosis (ATB) represents a significant proportion of tuberculosis (TB) cases. This study aimed to compare ATB and symptomatic TB (STB) cases in terms of demographic and clinical characteristics, adverse events, hospital length of stay, and treatment outcomes.</div></div><div><h3>Methods</h3><div>This multicenter retrospective study included 510 microbiologically confirmed pulmonary TB patients across ten Italian hospitals between 2018 and 2023. STB cases presented with at least one symptom such as cough, fever, chest pain, hemoptysis, dyspnea, night sweats or weight loss. ATB cases presented with no symptoms. The endpoints included adverse events, length of hospital stay, and incompleteness of the treatment.</div></div><div><h3>Results</h3><div>ATB accounted for 36.4 % of cases (184/510). STB was significantly associated with diabetes (p = 0.03), hepatitis B/C infections (p &lt; 0.0001), and history of TB (p = 0.01). Adjusting for clinically relevant confounders, STB was associated with higher occurrence of adverse events (odds ratio 2.04, 95 % confidence interval 1.31 to 3.23; p = 0.002), more severe adverse events (odds ratio 8.07, 95 % confidence interval 2.58 to 33.34; p = 0.001) and a 24 % increase in length of hospital stay (95 % confidence interval 7 % to 47 %; p = 0.005), but was not associated with incomplete treatment (odds ratio 0.79, 95 % confidence interval 0.47 to 1.32; p = 0.37).</div></div><div><h3>Conclusions</h3><div>STB is associated with a higher burden of adverse events. ATB poses challenges for TB elimination due to its asymptomatic nature.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100556"},"PeriodicalIF":2.0,"publicationDate":"2025-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144842512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving tuberculosis infection treatment completion among pregnant and postpartum women 提高孕妇和产后妇女结核病感染治疗的完成率
IF 2 Q3 INFECTIOUS DISEASES Pub Date : 2025-08-01 DOI: 10.1016/j.jctube.2025.100543
Kristen A. Wendorf , Lisa Armitige
{"title":"Improving tuberculosis infection treatment completion among pregnant and postpartum women","authors":"Kristen A. Wendorf ,&nbsp;Lisa Armitige","doi":"10.1016/j.jctube.2025.100543","DOIUrl":"10.1016/j.jctube.2025.100543","url":null,"abstract":"","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"40 ","pages":"Article 100543"},"PeriodicalIF":2.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuberculosis infection control in MDR-TB designated hospitals in Jiangsu Province, China 江苏省耐多药结核病定点医院结核病感染控制情况
IF 2 Q3 INFECTIOUS DISEASES Pub Date : 2025-07-29 DOI: 10.1016/j.jctube.2025.100555
Honghuan Song , Guoli Li , Zhuping Xu , Feixian Wang , Xiaoping Wang , Bing Dai , Xing Zhang , Jincheng Li , Yan Li , Limei Zhu

Background

Hospital-acquired Tuberculosis (TB) infections among healthcare workers (HCWs) and patients present a significant challenge due to the increased risk of TB infection within healthcare settings.

Methods

A standardized assessment tool was applied for the evaluation, which involved direct observation, document review, and interviews with facility heads. A baseline evaluation of TB infection control (TBIC) measures in TB outpatient and inpatient departments, as well as laboratories, was completed by January 2019. Based on the results, a comprehensive intervention package was implemented, incorporating a three-tiered hierarchy of controls: administrative control (AC), environmental control (EC), and respiratory protection (RP). Subsequent monitoring was conducted quarterly, with corrective actions accordingly. More than two years of follow-up data were collected, with the collaboration of local hospitals, the municipality Centers for Disease Control and Prevention (CDC), and the Jiangsu Provincial CDC, concluding on August 31, 2021.

Results

At baseline, the average implementation rates of AC, EC and RP were 57.3 %, 59.2 %, and 66.6 %, respectively. After the intervention, significant improvements were observed in key infection control measures. A triage process for cough patients was established, mechanical ventilation systems were installed, and the use of masks was improved. In addition, ultraviolet (UV) and upper-room ultraviolet germicidal irradiation (UVGI) systems were installed where required. As a result, the average implementation rates of AC, EC and RP significantly increased to 86.3 %, 87.4 %, and 98.4 % (P < 0.05), respectively. However, at the study’s conclusion, Suzhou Fifth People’s Hospital reported a lower AC implementation rate of 70.7 %, while Changzhou Third People’s Hospital had an EC implementation rate of 68.1 %. These discrepancies were primarily attributed to suboptimal architectural designs that hindered proper ventilation in the wards.

Conclusions

This study demonstrates that designated hospitals still face persistent gaps in tuberculosis infection control (TBIC). However, over the course of one and a half years of targeted and standardized interventions, substantial improvements in TBIC practices were achieved across most participating institutions. Despite the suboptimal availability of dedicated TB wards, strengthening TBIC measures remains crucial to reducing TB transmission among healthcare workers and non-TB patients. This approach is both practical and scalable, particularly in high-burden TB settings. Nevertheless, the long-term efficacy and sustainability of these TBIC practices warrant ongoing evaluation.
背景:卫生保健工作者(HCWs)和患者之间的医院获得性结核病(TB)感染由于卫生保健机构中结核病感染的风险增加而面临重大挑战。方法采用标准化评价工具进行评价,包括直接观察、文献查阅和设施负责人访谈。到2019年1月,完成了结核病门诊和住院部门以及实验室结核病感染控制(TBIC)措施的基线评估。根据研究结果,实施了综合干预方案,包括三层控制:行政控制(AC)、环境控制(EC)和呼吸保护(RP)。随后每季度进行一次监测,并采取相应的纠正措施。在当地医院、市疾病预防控制中心(CDC)和江苏省疾病预防控制中心的合作下,收集了两年多的随访数据,于2021年8月31日结束。结果基线时,AC、EC和RP的平均执行率分别为57.3%、59.2%和66.6%。干预后,主要感染控制措施有显著改善。建立咳嗽患者分诊流程,安装机械通气系统,改进口罩使用。此外,在需要的地方安装了紫外线(UV)和上层房间紫外线杀菌照射(UVGI)系统。结果,AC、EC和RP的平均执行率显著提高至86.3%、87.4%和98.4% (P <;分别为0.05)。然而,在研究结论中,苏州市第五人民医院的交流执行率较低,为70.7%,而常州市第三人民医院的交流执行率为68.1%。这些差异主要是由于不理想的建筑设计阻碍了病房的适当通风。结论本研究表明定点医院在结核病感染控制(TBIC)方面仍存在持续差距。然而,经过一年半的有针对性和标准化干预,大多数参与机构在TBIC实践方面取得了实质性进展。尽管专用结核病病房的可用性不够理想,但加强结核病防治措施对于减少卫生保健工作者和非结核病患者之间的结核病传播仍然至关重要。这种方法既实用又可扩展,特别是在高负担结核病环境中。然而,这些TBIC做法的长期效力和可持续性值得持续评估。
{"title":"Tuberculosis infection control in MDR-TB designated hospitals in Jiangsu Province, China","authors":"Honghuan Song ,&nbsp;Guoli Li ,&nbsp;Zhuping Xu ,&nbsp;Feixian Wang ,&nbsp;Xiaoping Wang ,&nbsp;Bing Dai ,&nbsp;Xing Zhang ,&nbsp;Jincheng Li ,&nbsp;Yan Li ,&nbsp;Limei Zhu","doi":"10.1016/j.jctube.2025.100555","DOIUrl":"10.1016/j.jctube.2025.100555","url":null,"abstract":"<div><h3>Background</h3><div>Hospital-acquired Tuberculosis (TB) infections among healthcare workers (HCWs) and patients present a significant challenge due to the increased risk of TB infection within healthcare settings.</div></div><div><h3>Methods</h3><div>A standardized assessment tool was applied for the evaluation, which involved direct observation, document review, and interviews with facility heads. A baseline evaluation of TB infection control (TBIC) measures in TB outpatient and inpatient departments, as well as laboratories, was completed by January 2019. Based on the results, a comprehensive intervention package was implemented, incorporating a three-tiered hierarchy of controls: administrative control (AC), environmental control (EC), and respiratory protection (RP). Subsequent monitoring was conducted quarterly, with corrective actions accordingly. More than two years of follow-up data were collected, with the collaboration of local hospitals, the municipality Centers for Disease Control and Prevention (CDC), and the Jiangsu Provincial CDC, concluding on August 31, 2021.</div></div><div><h3>Results</h3><div>At baseline, the average implementation rates of AC, EC and RP were 57.3 %, 59.2 %, and 66.6 %, respectively. After the intervention, significant improvements were observed in key infection control measures. A triage process for cough patients was established, mechanical ventilation systems were installed, and the use of masks was improved. In addition, ultraviolet (UV) and upper-room ultraviolet germicidal irradiation (UVGI) systems were installed where required. As a result, the average implementation rates of AC, EC and RP significantly increased to 86.3 %, 87.4 %, and 98.4 % (P &lt; 0.05), respectively. However, at the study’s conclusion, Suzhou Fifth People’s Hospital reported a lower AC implementation rate of 70.7 %, while Changzhou Third People’s Hospital had an EC implementation rate of 68.1 %. These discrepancies were primarily attributed to suboptimal architectural designs that hindered proper ventilation in the wards.</div></div><div><h3>Conclusions</h3><div>This study demonstrates that designated hospitals still face persistent gaps in tuberculosis infection control (TBIC). However, over the course of one and a half years of targeted and standardized interventions, substantial improvements in TBIC practices were achieved across most participating institutions. Despite the suboptimal availability of dedicated TB wards, strengthening TBIC measures remains crucial to reducing TB transmission among healthcare workers and non-TB patients. This approach is both practical and scalable, particularly in high-burden TB settings. Nevertheless, the long-term efficacy and sustainability of these TBIC practices warrant ongoing evaluation.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100555"},"PeriodicalIF":2.0,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144758056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of nontuberculous mycobacterial infections in Saudi children from a tertiary care hospital perspective 从三级医院的角度分析沙特儿童非结核分枝杆菌感染
IF 2 Q3 INFECTIOUS DISEASES Pub Date : 2025-07-26 DOI: 10.1016/j.jctube.2025.100554
Norah Abukhalid , Nabeel Alzahrani , Khaled Alsager , Banan Alsowailmi , Amjad Albawardi
We present a case series of six children who were infected with different species of Nontuberculous mycobacteria (NTM) and Mycobacterium riyadhense was the most prevalent isolate representing 50% of the total pathogens. Four of the reported cases were immunocompromised with disseminated NTM diseases and two were infected with M. avium, M. abscessus, and the other two infected with M. riyadhense. Most patients responded to medical therapy, except for the M. avium case, which was fatal despite combination therapy. Due to the presence of mycolic acid in the cell wall of NTM isolates, prolonged combination therapy is required for treatment, and in some cases, natural resistance may also emerge. Most of the patients reported in our study were immunocompetent. This suggests that NTM can infect children at various body sites regardless of immune status. We highlighted our experience in diagnosing and treating these patients, with special attention to M. riyadhense.
我们报告了6名感染不同种类非结核分枝杆菌(NTM)的儿童的病例系列,其中利雅德亨分枝杆菌是最常见的分离物,占总病原体的50%。报告的病例中有4例出现播散性NTM疾病的免疫功能低下,2例感染了鸟支原体、脓肿支原体,另外2例感染了利雅得支原体。大多数患者对药物治疗有反应,除了鸟支原体病例,尽管联合治疗,该病例仍是致命的。由于NTM分离株细胞壁中存在霉菌酸,需要长期联合治疗,在某些情况下,还可能出现自然耐药性。我们研究中报告的大多数患者具有免疫功能。这表明NTM可以感染儿童的各个身体部位,而不管免疫状态如何。我们强调了我们在诊断和治疗这些患者方面的经验,特别关注了利雅得氏分枝杆菌。
{"title":"Analysis of nontuberculous mycobacterial infections in Saudi children from a tertiary care hospital perspective","authors":"Norah Abukhalid ,&nbsp;Nabeel Alzahrani ,&nbsp;Khaled Alsager ,&nbsp;Banan Alsowailmi ,&nbsp;Amjad Albawardi","doi":"10.1016/j.jctube.2025.100554","DOIUrl":"10.1016/j.jctube.2025.100554","url":null,"abstract":"<div><div>We present a case series of six children who were infected with different species of<!--> <!-->Nontuberculous mycobacteria (NTM) and <em>Mycobacterium riyadhense</em> was the most prevalent isolate representing 50% of the total pathogens. Four of the reported cases were immunocompromised with disseminated NTM diseases and two were infected with <em>M. avium</em>, <em>M. abscessus</em>, and the other two infected with <em>M. riyadhense</em>. Most patients responded to medical therapy, except for the <em>M. avium</em> case, which was fatal despite combination therapy. Due to the presence of mycolic acid in the cell wall of NTM isolates, prolonged combination therapy is required for treatment, and in some cases, natural resistance may also emerge<del>.</del> Most of the patients reported in our study were immunocompetent. This suggests that NTM can infect children at various body sites regardless of immune status. We highlighted our experience in diagnosing and treating these patients, with special attention to <em>M. riyadhense</em>.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100554"},"PeriodicalIF":2.0,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144826945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective analysis of systemic lupus erythematosus patients with latent tuberculosis infection: A 5-year follow-up study 系统性红斑狼疮合并潜伏性结核感染的回顾性分析:一项5年随访研究
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-07-17 DOI: 10.1016/j.jctube.2025.100553
Yiling Zhang , Gengmin Zhou , Hongli Wang , Qingwen Wang , Guofang Deng
Patients with systemic lupus erythematosus (SLE) have a higher incidence of tuberculosis (TB)infection compared to the general healthy population. The use of glucocorticoids and immunosuppressive agents for SLE management further elevates TB risk. This study aimed to evaluate the prevalence of latent tuberculosis infection (LTBI) in SLE patients and explore risk factors for progression to active TB (ATB) in those with concurrent SLE and LTBI. We conducted a retrospective analysis of SLE patients treated at the Department of Rheumatology and Immunology, Peking University Shenzhen Hospital, between 2014 and 2023. During a five − year follow − up period, LTBI was detected in 122 patients (24.11%). Of these, 11 individuals (all from the subgroup of 108 patients who did not receive tuberculosis preventive treatment [TPT]) progressed to ATB. A comparative analysis between the 11 ATB cases and 111 non-progressing LTBI patients revealed significant differences: ATB cases showed higher cyclophosphamide (CTX) usage, elevated high-sensitivity C-reactive protein (hs-CRP) levels, and less frequent hydroxychloroquine (HCQ)administration. These findings underscore the need for regular monitoring during prolonged CTX therapy, especially in moderate-to-high TB burden regions, and highlight the potential protective role of HCQ.
与一般健康人群相比,系统性红斑狼疮(SLE)患者结核病(TB)感染的发生率更高。在SLE治疗中使用糖皮质激素和免疫抑制剂进一步增加了结核病的风险。本研究旨在评估SLE患者潜伏性结核感染(LTBI)的患病率,并探讨并发SLE和LTBI的患者进展为活动性结核(ATB)的危险因素。我们对2014年至2023年间在北京大学深圳医院风湿病免疫科治疗的SLE患者进行了回顾性分析。在5年的随访期间,122例患者(24.11%)检测到LTBI。其中,11人(全部来自108名未接受结核病预防性治疗的患者亚组)进展为ATB。11例ATB患者与111例非进展性LTBI患者的比较分析显示了显著差异:ATB患者环磷酰胺(CTX)使用率较高,高敏c反应蛋白(hs-CRP)水平升高,羟氯喹(HCQ)使用频率较低。这些发现强调了在长期CTX治疗期间定期监测的必要性,特别是在结核病中至高负担地区,并强调了HCQ的潜在保护作用。
{"title":"Retrospective analysis of systemic lupus erythematosus patients with latent tuberculosis infection: A 5-year follow-up study","authors":"Yiling Zhang ,&nbsp;Gengmin Zhou ,&nbsp;Hongli Wang ,&nbsp;Qingwen Wang ,&nbsp;Guofang Deng","doi":"10.1016/j.jctube.2025.100553","DOIUrl":"10.1016/j.jctube.2025.100553","url":null,"abstract":"<div><div>Patients with systemic lupus erythematosus (SLE) have a higher incidence of tuberculosis (TB)infection compared to the general healthy population. The use of glucocorticoids and immunosuppressive agents for SLE management further elevates TB risk. This study aimed to evaluate the prevalence of latent tuberculosis infection (LTBI) in SLE patients and explore risk factors for progression to active TB (ATB) in those with concurrent SLE and LTBI. We conducted a retrospective analysis of SLE patients treated at the Department of Rheumatology and Immunology, Peking University Shenzhen Hospital, between 2014 and 2023. During a five − year follow − up period, LTBI was detected in 122 patients (24.11%). Of these, 11 individuals (all from the subgroup of 108 patients who did not receive tuberculosis preventive treatment [TPT]) progressed to ATB. A comparative analysis between the 11 ATB cases and 111 non-progressing LTBI patients revealed significant differences: ATB cases showed higher cyclophosphamide (CTX) usage, elevated high-sensitivity C-reactive protein (hs-CRP) levels, and less frequent hydroxychloroquine (HCQ)administration. These findings underscore the need for regular monitoring during prolonged CTX therapy, especially in moderate-to-high TB burden regions, and highlight the potential protective role of HCQ.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"40 ","pages":"Article 100553"},"PeriodicalIF":1.9,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144696731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OMNIgene.SPUTUM for transporting sputum in ambient temperature for tuberculosis testing: Bangladesh experience OMNIgene。在环境温度下运输痰液用于结核病检测:孟加拉国的经验
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-07-14 DOI: 10.1016/j.jctube.2025.100552
Senjuti Kabir , Sabrina Choudhury , Mohammad Khaja Mafij Uddin , M.D. Fahim Ather , Syed Mohammad Mazidur Rahman , Pronab Kumar Modak , Mohammad Samsuddoha Sarker Shanchay , Tanjina Rahman , Shahriar Ahmed , Sayera Banu

Background

Performance of OMNIgene.SPUTUM (OM-S) for transporting sputum was evaluated.

Methods

This exploratory study was conducted during January-December 2019 at four near and one distant healthcare-facilities of Dhaka. Smear-positive pulmonary TB patients’ sputa were collected, divided into ‘OM-S untreated’ and ‘OM-S treated’ portions, and transported to testing laboratory, Dhaka, on same-day from near-sites, and through courier from distant-site for smear-microscopy, culture, and Xpert MTB/RIF (Xpert) testing. Subset of ‘OM-S treated’ sample was tested with Xpert without centrifugation. Test results of all portions were compared in between.

Results

Total 444 participants were enrolled (near-sites:198, distant-site: 246). All test results were comparable in both portions for near-sites. For distant-site, smear-microscopy’s positivity was reduced by 4.1 % in ‘OM-S treated’, Xpert showed 100 % concordance in both portions, and culture was higher in ‘OM-S treated’ than ‘OM-S untreated’ (92.3 % vs 89.4 %; p = 0.288). Primary contamination rate in ‘OM-S treated’ was lower than ‘OM-S untreated’ (2.0 % vs 9.8 %; p < 0.05). For all sites, median (IQR) time-to-culture positivity was 35 (28, 42) days in both portions. Xpert positivity was 99 % concordant in ‘OM-S treated’ regardless of centrifugation.

Conclusions

OM-S is safe for sputum transportation. OM-S mixed sputum can be tested with Xpert and culture. Further studies can validate findings and assess cost-effectiveness.
OMNIgene的背景性能。痰液(OM-S)用于痰液运输。方法本探索性研究于2019年1月至12月在达卡的四家近距离医疗机构和一家远距离医疗机构进行。收集痰液阳性肺结核患者的痰液,将其分为“未经OM-S治疗”和“OM-S治疗”两部分,并于当天从近地点和从远地点通过快递运送到达卡检测实验室,进行涂片显微镜、培养和Xpert MTB/RIF (Xpert)检测。“OM-S处理”样品的子集在不离心的情况下用Xpert进行测试。比较各部分的试验结果。结果共纳入受试者444例(近点198例,远点246例)。所有的测试结果在近地点的两个部分具有可比性。对于远处部位,“OM-S处理”的涂片显微镜阳性降低了4.1%,Xpert在两个部分显示100%的一致性,“OM-S处理”的培养高于“OM-S未处理”(92.3% vs 89.4%;p = 0.288)。“OM-S处理”组的初级污染率低于“OM-S未处理”组(2.0% vs 9.8%;p & lt;0.05)。对于所有站点,两个部分的中位(IQR)培养阳性时间为35(28,42)天。无论离心与否,“OM-S处理”的专家阳性结果一致性为99%。结论som - s用于痰液运输是安全的。OM-S混合痰液可以用Xpert法和培养法检测。进一步的研究可以验证研究结果并评估成本效益。
{"title":"OMNIgene.SPUTUM for transporting sputum in ambient temperature for tuberculosis testing: Bangladesh experience","authors":"Senjuti Kabir ,&nbsp;Sabrina Choudhury ,&nbsp;Mohammad Khaja Mafij Uddin ,&nbsp;M.D. Fahim Ather ,&nbsp;Syed Mohammad Mazidur Rahman ,&nbsp;Pronab Kumar Modak ,&nbsp;Mohammad Samsuddoha Sarker Shanchay ,&nbsp;Tanjina Rahman ,&nbsp;Shahriar Ahmed ,&nbsp;Sayera Banu","doi":"10.1016/j.jctube.2025.100552","DOIUrl":"10.1016/j.jctube.2025.100552","url":null,"abstract":"<div><h3>Background</h3><div>Performance of OMNIgene.SPUTUM (OM-S) for transporting sputum was evaluated.</div></div><div><h3>Methods</h3><div>This exploratory study was conducted during January-December 2019 at four near and one distant healthcare-facilities of Dhaka. Smear-positive pulmonary TB patients’ sputa were collected, divided into ‘OM-S untreated’ and ‘OM-S treated’ portions, and transported to testing laboratory, Dhaka, on same-day from near-sites, and through courier from distant-site for smear-microscopy, culture, and Xpert MTB/RIF (Xpert) testing. Subset of ‘OM-S treated’ sample was tested with Xpert without centrifugation. Test results of all portions were compared in between.</div></div><div><h3>Results</h3><div>Total 444 participants were enrolled (near-sites:198, distant-site: 246). All test results were comparable in both portions for near-sites. For distant-site, smear-microscopy’s positivity was reduced by 4.1 % in ‘OM-S treated’, Xpert showed 100 % concordance in both portions, and culture was higher in ‘OM-S treated’ than ‘OM-S untreated’ (92.3 % vs 89.4 %; p = 0.288). Primary contamination rate in ‘OM-S treated’ was lower than ‘OM-S untreated’ (2.0 % vs 9.8 %; p &lt; 0.05). For all sites, median (IQR) time-to-culture positivity was 35 (28, 42) days in both portions. Xpert positivity was 99 % concordant in ‘OM-S treated’ regardless of centrifugation.</div></div><div><h3>Conclusions</h3><div>OM-S is safe for sputum transportation. OM-S mixed sputum can be tested with Xpert and culture. Further studies can validate findings and assess cost-effectiveness.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"40 ","pages":"Article 100552"},"PeriodicalIF":1.9,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144634174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1